Related Experiment Videos

Liposomal microparticle injection can induce myeloid-derived suppressor cells (MDSC)-like cells in vivo

Hiroshi Azuma1, Yoichiro Yoshida1, Hironori Takahashi1

  • 1a Department of Pediatrics , Asahikawa Medical University , Asahikawa , Japan.

Abstract

Insights

Liposomal microparticles can induce myeloid-derived suppressor cells (MDSCs) in vivo, suppressing T-cell proliferation. This effect is dose-dependent and mediated by inducible nitric oxide synthase (iNOS).

Area of Science:

  • Immunology
  • Cell Biology
  • Nanomedicine

Background:

  • Myeloid-derived suppressor cells (MDSCs) are critical immunosuppressive cells in pathological conditions.
  • Membrane-derived microvesicles are implicated in MDSC induction.
  • Liposomes are known to suppress T-cell proliferation, with nitric oxide (NO) involvement.

Purpose of the Study:

  • To investigate if liposomal microparticles can induce MDSC-like cells in vivo.
  • To determine the dose-dependency of liposome-induced immunosuppression.
  • To assess liposome effects on inducible NO synthase (iNOS), T-cell proliferation, and cytokine production.

Main Methods:

  • Preparation of 250 nm liposome particles and intravenous injection into rats.
  • Evaluation of T-cell proliferation (Concanavalin A and anti-CD3 stimulated) 24 hours post-injection.
  • Measurement of iNOS, NO, and cytokine production in rat splenocytes.

Main Results:

  • Liposome injection suppressed T-cell proliferation in a dose-dependent manner.
  • iNOS was detected in liposome-loaded splenocytes, and suppression was abrogated by an iNOS inhibitor.
  • Anti-CD3 stimulated T-cell proliferation was inhibited, with enhanced IL-10 production observed.

Conclusions:

  • Liposomal microparticles effectively induce MDSC-like cells in vivo.
  • The lipids within liposomes play a significant role in inducing MDSCs.
  • This suggests a potential therapeutic strategy for modulating immune responses.

Related Concept Videos